2023 Publications

165. Ahmed, H.; Wallimann, R.; Gisler, L.; Elghazawy, N. H.; Gruber, S.; Keller, C.; Liang, S. H.; Sippl, W.; Haider, A. and Ametamey, S. M. “Characterization of (R)- and (S)-[¹⁸F]OF-NB1 in Rodents as Positron Emission Tomography Probes for Imaging GluN2B Subunit-Containing N-Methyl-D-Aspartate Receptors”, ACS Chemical Neuroscience, 2023, accepted.

164. Zhang, J.-J.; Lou, L.; Lv, R.; Chen, J.; Li, Y.; Wu, G.; Cai, L.; Liang, S. H. and Chen, Z. “Recent advances in photochemistry for positron emission tomography imaging”, Chin. Chem. Lett. 2023, accepted.

163. Yoo, C-H; DuBois, J.; Wang, L.; Tang, Y.; Hou, L.; Xu, H.; Chen, J.; Liang, S. H.; Izquierdo Garcia, D. and Wey, H-Y. “Positron Pseudo-CT-based attenuation correction to simultaneous PET/MRI brain imaging of non-human primates”, ACS Omega, 2023, accepted.

162. Chen, J.; Ran, W.; Huang, Y.;Wei, J.; Rong, J.; Wei, H.; Li, Y.; Li, G.; Chen, Z.; Collier, L.; Elghazawy, N. H.; Sippl, W.; Haider, A.; Liao, K.; Dong, C.; Li, Y.; Xu, H.; He, W.; Wang, L. and Liang, S. H. “Evaluation of Thiadiazine-Based PET Radioligands for Imaging the AMPA Receptor”, Biomedicine & Pharmacotherapy, 2023, accepted.

161. Korff, M.; Chaudhary, A.; Li, Y.; Zhou, X.; Zhao, C.; Rong, J.; Chen, J.; Xiao, Z.; Elghazawy, N.; Sippl, W.; Davenport, A.; Daunais, J. B.; Wang, L.; Abate, C.; Ahmed, H.; Crowe, R.; Schmidt, T. J. ; Liang, S. H.; Ametamey, S. M.; Wünsch, B. and Haider, A. “Synthesis and Biological Evaluation of Enantiomerically Pure (R)- and (S)-[¹⁸F]OF-NB1 for Imaging the GluN2B Subunit-Containing NMDA receptors”, Journal of Medicinal Chemistry, 2023, accepted.

160. Rong, J.; Yamasaki, T.; Li, Y.; Kumata, K.; Zhao, C.; Haider, A.; Chen, J.; Xiao, Z.; Fujinaga, M.; Hu, K.; Mori, W.; Zhang, Y.; Xie, L.; Zhou, X.; Collier, T. L.; Zhang, M.-R. and Liang, S. H. “Development of Novel ¹¹C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging”, ACS Medicinal Chemistry Letters 2023, accepted.

159. Kuang, S.; Zhu, B., Zhang, J., Yang, F., Wu, B., Ding, W., Yang, L., Shen, S., Liang, S. H., Mondal, P., Kumar, M., Tanzi, R. E., Zhang, C., Chao, H. and Ran, C. “A Photolabile Curcumin-Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer’s Disease Treatment”, Angewandte Chemie International Edition, 2023, doi: 10.1002/anie.202312519.

158. Haider, A.; Wang, L.; Gobbi, L.; Li, Y.; Chaudhary, A.; Zhou, X.; Chen, J.; Zhao, C.; Rong, J.; Xiao, Z.; Hou, L.; Elghazawy, N.H.; Sippl, W.; Davenport, A.T.; Daunais, J.B.; Ahmed, H.; Crowe, R.; Honer, M.; Rominger, A.; Grether, U.; Liang, S. H. and Ametamey S.M. “Evaluation of [¹⁸F]RoSMA-18-d₆ as a CB2 PET Radioligand in Non-Human Primates”, ACS Chemical Neuroscience, 2023, Accepted.

157. Li, W.; Qiao, Y.; Chen, J.; Li, Y.; Du, X.; Liang, S. H. and Fu, H. “Visualizing Reactive Astrocytes: Positron Emission Tomography Imaging Ligands for Imidazoline-2 Binding Sites”, View, 2023, Accepted.

156. Song, R., Zhang, J., Perszyk, R. E., Chad, R C., Tang, W., Kannan, V., Li, J., Xu, Y., Chen, J., Li, Y., Liang, S. H., Traynelis, S. F., & Yuan, H. (2023) “Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors”, Journal of Neurochemistry, 2023, Accepted. 

155. Zhang, J-J., Fu, H., Lin, R., Zhou, J. Haider, A., Fang, W., Elghazawy, N., Rong, J., Chen, J., Li, Y., Ran, C., Collier, L., Chen, Z., and Liang, S. H. “Imaging cholinergic receptors in the brain by positron emission tomography”, Journal of Medicinal Chemistry, 2023, accepted.

154. Chasse, M., Pees, A., Lindberg, A., Liang, S. H. and Vasdev, N. “Spirocyclic Iodonium Ylides for Fluorine-18 Radiolabeling of Non-Activated Arenes: From Concept to Clinical Research”, Chem. Rec. 2023, e202300072. DOI link: doi.org/10.1002/tcr.202300072 

153. Rong, J., Zhao, C., Xia, X., Li, G., Haider, A., Wei, H., Chen, J., Xiao, Z., Li, Y., Zhou, X., Xu, H., Collier, T.L., Wang, L. and Liang, S. H.  “Evaluation of [¹⁸F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission Tomography”, Pharmaceuticals, 2023,16(4):524. Link doi: 10.3390/ph16040524.

152. Zhu, B., Liang, S. H. and Ran, C. “Imaging Brown Adipose Tissue with TSPO PET Tracers in Preclinical Animal Studies”, Methods Mol Biol, 2023, 2662:147-156. doi: 10.1007/978-1-0716-3167-6_13.

151. Guo, B., Hu, L., Cai, Q., Cheng, Y., Shang, J., Tang, Y., Ling, X., Gong, J., Liang, S. H., Wang, L. and Xu, H. “Precision of quantitative parameters of ¹⁸F-FDG PET/CT in a rabbit VX2 tumor model”, Quantitative Imaging in Medicine and Surgery, 2023, Link: https://qims.amegroups.com/article/view/112844

150. Haider, A., Elghazawy, N. H., Dawood, A., Gebhard, C., Wichmann, T., Sippl, W., Hoener, M., Arenas, E. and Liang, S. H. “Translational molecular imaging and drug development in Parkinson’s disease”, Molecular Neurodegeneration, 2023, 18(1):11. doi: 10.1186/s13024-023-00600-z. Link: https://pubmed.ncbi.nlm.nih.gov/36759912/

149. Rong, J., Haider, A., Jeppesen, T. E., Josephson, L. & Liang, S. H. “Radiochemistry for Positron Emission Tomography”, Nature Communications, 2023, Accepted.

148. Tan, Z., Haider, A., Zhang, S., Chen, J., Wei, J., Liao, K., Li, G., Wei, H., Dong, C., Ran, W., Li, Y., Li, Y., Rong, J., Li, Y., Liang, S. H., Xu, H. and Wang, L. “Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [¹⁸F]LW223 as a TSPO-targeted PET radioligand”, Pharmacol Res. 2023 Feb 4:106681. doi: 10.1016/j.phrs.2023.106681.  Link: https://pubmed.ncbi.nlm.nih.gov/36746361/

147. Zeng, X.; Wang, C.; Yan, W.; Rong, J.; Song, Y.; Xiao, Z.; Cai, A.; Liang, S. H. and Liu, W. “Aryl Radical Enabled, Copper–Catalyzed Sonogashira-Type Cross-Coupling of Alkynes with Alkyl Iodides”, ACS Catalysis, 2023, 13, 4, 2761–2770. Link: https://pubs.acs.org/doi/10.1021/acscatal.2c05901

146. Yamasaki, T., Ishii, H., Hiraishi, A., Kumata, K., Wakizaka, H., Zhang, Y., Kurihara, Y., Ogawa, M., Nengaki, N., Chen, J., Li, Y., Liang, S. H. and Zhang M.-R. “Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein γ-8 (TARP γ-8) in the brain”,  Journal of Cerebral Blood Flow & Metabolism, 2023 Jan 18:271678X231152025. doi: 10.1177/0271678X231152025.  Link: https://journals.sagepub.com/doi/10.1177/0271678X231152025

145. Yoo, C.H., Chen, Z., Rani, N., Chen, J., Rong, J., Chen, L., Zhang, L., Liang, S. H. and Wey, H. Y. “Evaluation of [¹⁸F]PF-06455943 as a Potential LRRK2 PET Imaging Agent in the Brain of Nonhuman Primates”, ACS Chem Neurosci. 2023 Jan 11. doi: 10.1021/acschemneuro.2c00466. Link: https://pubmed.ncbi.nlm.nih.gov/36630128/

144. Chen, Z., Chen, J., Chen, L., Yoo, C. H., Rong, J., Fu, H., Shao, T., Coffman, K., Steyn, S. J., Davenport, A. T., Daunais, J. B., Haider, A., Collier, L., Josephson, L., Wey, H. Y., Zhang, L. and Liang. S. H. “Imaging Leucine-Rich Repeat Kinase 2 In Vivo with 18F-Labeled Positron Emission Tomography Ligand”, Journal of Medicinal Chemistry, 2022, accepted. Link: https://pubmed.ncbi.nlm.nih.gov/36256881/